BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:     

In Silico ADME/Tox Products Market 2006

In Silico ADME/Tox Products Market 2006


In Silico predictive ADME/Tox screening is one of the hottest areas in drug discovery. It is widely perceived that the early screening of chemical entities can significantly reduce the expensive costs associated with late stage failures of drugs due to poor ADME/Tox properties. This market research report from Select Biosciences provides an up-to-date overview and analysis of technology, business, regulatory trends and key product profiles.

In this report Select Biosciences presents an analysis of the In Silico ADME/Tox market landscape. Although, the market is at an embryonic stage of development, the insurgence in the number of companies and products offered to this market clearly reflects significant opportunity.

Furthermore, in this report qualitative and quantitative market analysis of In Silico ADME/Tox products is presented. Also presented is the potential market opportunity, and the various factors that are driving and/or restraining the growth of this market.

Key Highlights of this report:

Overview of the drug discovery process

Regulatory requirements for drug approval

The importance of ADME/Tox screening in drug discovery

Market Drivers and Restraints

Industry Challenges

In Silico ADME/Tox screening product analysis

Quantitative market research

Competitive Factors

Published: June 2006, Pages: 180
Table of Contents
Table of Contents



Price
Single User Print Version $2,500.00   
Electronic Site License (pdf + one print copy) $3,000.00   



Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.

Back to top